Literature DB >> 8478083

Analysis of Candida albicans adhesion to salivary mucin.

M P Hoffman1, C G Haidaris.   

Abstract

Clearance of Candida albicans from the oral cavity is thought to be mediated via specific receptor-ligand interactions between salivary constituents and the fungus. Since surfaces in the oral cavity are normally coated with a saliva-derived pellicle, specific interactions between salivary constituents and C. albicans may also contribute to adhesion of C. albicans to the oral mucosa and dental prostheses. Therefore, the purpose of this study was to identify salivary constituents to which C. albicans is capable of binding. A solid-phase overlay assay was used in which electrophoretically separated rat and human salivary constituents bound to membrane filters were incubated with radiolabelled C. albicans cells. C. albicans adhered to a single salivary component from each host. Correlation of cell-binding activity with specific monoclonal antibody (MAb)-binding activity indicated that the constituent bound by C. albicans in human saliva was low-molecular-weight mucin (MG2) and that in rat saliva was rat submandibular gland (RSMG) mucin. Further studies showed an identical cell hybridization signal and MAb colocalization by using RSMG ductal saliva and an aqueous RSMG extract in the solid-phase overlay assay. Analysis of cell binding to the aqueous extract of RSMG fractionated by anion-exchange chromatography demonstrated that C. albicans binding was restricted to an acidic subfraction of the RSMG extract, which also bound the RSMG mucin-specific MAb. The Candida-binding fraction contained predominantly RSMG mucin glycoprotein and also a noncovalently associated, chloroform-extractable material. Furthermore, we identified two strains of C. albicans which differed severalfold in the ability to bind RSMG mucin in the overlay assay. These results suggest that C. albicans binds to only a specific subfraction of RSMG mucin and that the two C. albicans strains tested differ in the ability to bind RSMG mucin subfractions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8478083      PMCID: PMC280787          DOI: 10.1128/iai.61.5.1940-1949.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Oral symptoms and candida in the terminally ill.

Authors:  I G Finlay
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-01

2.  Adsorption of human salivary mucins to hydroxyapatite.

Authors:  L A Tabak; M J Levine; N K Jain; A R Bryan; R E Cohen; L D Monte; S Zawacki; G H Nancollas; A Slomiany; B L Slomiany
Journal:  Arch Oral Biol       Date:  1985       Impact factor: 2.633

3.  Overlay and solid-phase analysis of glycolipid receptors for bacteria and viruses.

Authors:  K A Karlsson; N Strömberg
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Mucus glycoprotein of human saliva: differences in the associated and covalently bound lipids with caries.

Authors:  B L Slomiany; V L Murty; A Slomiany; J Zielenski; I D Mandel
Journal:  Biochim Biophys Acta       Date:  1986-06-03

Review 5.  The common mucosal immune system and current strategies for induction of immune responses in external secretions.

Authors:  J Mestecky
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

6.  Isolation and characterization of a mucin-glycoprotein from rat submandibular glands.

Authors:  L A Tabak; L Mirels; L D Monte; A L Ridall; M J Levine; R E Loomis; F Lindauer; M S Reddy; B J Baum
Journal:  Arch Biochem Biophys       Date:  1985-11-01       Impact factor: 4.013

7.  In vitro inhibition of adhesion of Candida albicans clinical isolates to human buccal epithelial cells by Fuc alpha 1----2Gal beta-bearing complex carbohydrates.

Authors:  D Brassart; A Woltz; M Golliard; J R Neeser
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

8.  Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans.

Authors:  J J Pollock; L Denepitiya; B J MacKay; V J Iacono
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

9.  The primary structure and functional characterization of the neutral histidine-rich polypeptide from human parotid secretion.

Authors:  F G Oppenheim; Y C Yang; R D Diamond; D Hyslop; G D Offner; R F Troxler
Journal:  J Biol Chem       Date:  1986-01-25       Impact factor: 5.157

10.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

View more
  23 in total

1.  Interaction of the salivary low-molecular-weight mucin (MG2) with Actinobacillus actinomycetemcomitans.

Authors:  J Groenink; A J Ligtenberg; E C Veerman; J G Bolscher; A V Nieuw Amerongen
Journal:  Antonie Van Leeuwenhoek       Date:  1996-07       Impact factor: 2.271

Review 2.  Cell wall and secreted proteins of Candida albicans: identification, function, and expression.

Authors:  W L Chaffin; J L López-Ribot; M Casanova; D Gozalbo; J P Martínez
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

3.  The recombinant N-terminal region of human salivary mucin MG2 (MUC7) contains a binding domain for oral Streptococci and exhibits candidacidal activity.

Authors:  B Liu; S A Rayment; C Gyurko; F G Oppenheim; G D Offner; R F Troxler
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

4.  Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase.

Authors:  A R Colina; F Aumont; N Deslauriers; P Belhumeur; L de Repentigny
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

Review 5.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

6.  CD86 (B7-2), but not CD80 (B7-1), expression in the epidermis of transgenic mice enhances the immunogenicity of primary cutaneous Candida albicans infections.

Authors:  A A Gaspari; R Burns; A Nasir; D Ramirez; R K Barth; C G Haidaris
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 7.  Glycan recognition at the saliva - oral microbiome interface.

Authors:  Benjamin W Cross; Stefan Ruhl
Journal:  Cell Immunol       Date:  2018-08-18       Impact factor: 4.868

Review 8.  Innate Immunity and Saliva in Candida albicans-mediated Oral Diseases.

Authors:  O Salvatori; S Puri; S Tati; M Edgerton
Journal:  J Dent Res       Date:  2016-01-08       Impact factor: 6.116

9.  Reduced inhibition of Candida albicans adhesion by saliva from patients receiving oral cancer therapy.

Authors:  M Umazume; E Ueta; T Osaki
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

10.  Identification of salivary mucin MUC7 binding proteins from Streptococcus gordonii.

Authors:  Mehmet Kesimer; Nedret Kiliç; Ravi Mehrotra; David J Thornton; John K Sheehan
Journal:  BMC Microbiol       Date:  2009-08-11       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.